Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression

Author:

Martínez-Castillo Moisés,Rosique-Oramas Dorothy,Medina-Avila Zaira,Pérez-Hernández José Luis,Higuera-De la Tijera Fatima,Santana-Vargas Daniel,Montalvo-Jave Eduardo Esteban,Sanchez-Avila Francico,Torre Aldo,Kershenobich David,Gutierrez-Reyes Gabriela

Funder

Consejo Nacional de Ciencia y Tecnología

Universidad Autónoma del Estado de México

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Reference44 articles.

1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2018) Burden of liver diseases in the world. J Hepatol. https://doi.org/10.1016/j.jhep.2018.09.014

2. Williams R, Alexander G, Armstrong I, Baker A, Bhala N, Camps-Walsh G, Cramp ME, de Lusignan S, Day N, Dhawan A, Dillon J, Drummond C, Dyson J, Foster G, Gilmore I, Hudson M, Kelly D, Langford A, McDougall N, Meier P, Moriarty K, Newsome P, O'Grady J, Pryke R, Rolfe L, Rice P, Rutter H, Sheron N, Taylor A, Thompson J, Thorburn D, Verne J, Wass J, Yeoman A (2018) Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK. Lancet 391:1097–1107. https://doi.org/10.1016/S0140-6736(17)32866-0

3. Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, Ghany MG, Mills AS, Nash SR, Govindarajan S, Rogers TE, Greenson JK, Brunt EM, Bonkovsky HL, Morishima C, Litman HJ (2010) Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 51:585–594. https://doi.org/10.1002/hep.23315

4. Zoubek ME, Trautwein C, Strnad P (2017) Reversal of liver fibrosis: from fiction to reality. Best Pract Res Clin Gastroenterol 31:129–141. https://doi.org/10.1016/j.bpg.2017.04.005

5. Nallagangula KS, Nagaraj SK, Venkataswamy L, Chandrappa M (2018) Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci Oa. https://doi.org/10.4155/Fsoa-2017-0083

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3